Nomura, T., Yamasaki, M., Hirai, K., Inoue, T., Sato, R., Matsuura, K., . . . Mimata, H. (2013). Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia. BioMed Central.

Nomura, Takeo, Mutsushi Yamasaki, Kenichi Hirai, Toru Inoue, Ryuta Sato, Keiko Matsuura, Masatsugu Moriyama, Fuminori Sato, and Hiromitsu Mimata. Targeting the Vav3 Oncogene Enhances Docetaxel-induced Apoptosis Through the Inhibition of Androgen Receptor Phosphorylation in LNCaP Prostate Cancer Cells Under Chronic Hypoxia. BioMed Central, 2013.

Nomura, Takeo, et al. Targeting the Vav3 Oncogene Enhances Docetaxel-induced Apoptosis Through the Inhibition of Androgen Receptor Phosphorylation in LNCaP Prostate Cancer Cells Under Chronic Hypoxia. BioMed Central, 2013.